BioXcel Therapeutics (BTAI) Assets (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Assets of $34.0 million for Q1 2026, down 11.77% year-over-year from $38.6 million in Q1 2025, and down 24.25% quarter-over-quarter from $44.9 million in Q4 2025.
BioXcel Therapeutics (BTAI) Assets (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Assets history runs 10 years deep, the most recent figure standing at $34.0 million for Q1 2026.
- In Q1 2026, Assets fell 11.77% year-over-year to $34.0 million; the TTM figure through Mar 2026 stood at $34.0 million (down 11.77% YoY), while the FY2025 annual figure was $44.9 million, up 17.16% from the prior year.
- Assets for Q1 2026 stood at $34.0 million, down from $44.9 million in the prior quarter.
- The five-year high for Assets was $248.2 million in Q2 2022, with the low at $25.8 million in Q2 2025.
- The 5-year median for Assets is $73.7 million (2023), against an average of $107.5 million.
- The sharpest annual moves came in 2023 and 2025: Assets plunged 64.2% in 2023, then climbed 17.16% in 2025.
- BioXcel Therapeutics' Assets stood at $205.9 million in 2022, then slumped by 64.2% to $73.7 million in 2023, then slumped by 47.98% to $38.3 million in 2024, then gained by 17.16% to $44.9 million in 2025, then decreased by 24.25% to $34.0 million in 2026.
- Business Quant data shows BTAI's Assets at $34.0 million in Q1 2026, $44.9 million in Q4 2025, and $44.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 6.18 Bn |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 | 28.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.80 Mn |
| Mar 31, 2026 | 34.03 Mn |
| Dec 31, 2025 | 44.92 Mn |
| Sep 30, 2025 | 44.79 Mn |
| Jun 30, 2025 | 25.79 Mn |
| Mar 31, 2025 | 38.57 Mn |
| Dec 31, 2024 | 38.34 Mn |
| Sep 30, 2024 | 48.89 Mn |
| Jun 30, 2024 | 65.44 Mn |
| Mar 31, 2024 | 82.32 Mn |
| Dec 31, 2023 | 73.70 Mn |
| Sep 30, 2023 | 100.45 Mn |
| Jun 30, 2023 | 140.10 Mn |
| Mar 31, 2023 | 180.10 Mn |
| Dec 31, 2022 | 205.85 Mn |
| Sep 30, 2022 | 244.82 Mn |
| Jun 30, 2022 | 248.24 Mn |
| Mar 31, 2022 | 211.05 Mn |
| Dec 31, 2021 | 239.44 Mn |
| Sep 30, 2021 | 261.33 Mn |